, including in the sections captioned Cautionary Note Regarding Forward-Looking Statements and Item 1A. Risk Factors, in the companys most recently filed Quarterly Report on Form 10-Q and in the companys subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Any forward-looking statement made in this statement speaks only as of the date of this statement. Neither the Janssen Pharmaceutical Companies nor Johnson & Johnson undertakes to update any forward-looking statement as a result of new information or future events or developments. The Company expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this statement.
6.7 C
London
Thursday, December 19, 2024